Average Co-Inventor Count = 6.97
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada & Co. (4 from 76 patents)
2. Merck Canada Inc. (3 from 40 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Merck Frosst Canada, Inc. (2 from 212 patents)
9 patents:
1. 8735417 - Aminopyrimidines as Syk inhibitors
2. 8551984 - Aminopyrimidines as SYK inhibitors
3. 8486975 - Non-nucleoside reverse transcriptase inhibitors
4. 7943649 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
5. 7442716 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
6. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
7. 6639077 - Tri-aryl-substituted-ethane PDE4 inhibitors
8. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors
9. 6200993 - Heterosubstituted pyridine derivatives as PDE4 inhibitors